Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.

Item

http://www.wikidata.org/entity/Q38142792

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Selective and specific inhibit ...... tery disease or heart failure.

@en

type

Item

label

Selective and specific inhibit ...... tery disease or heart failure.

@en

prefLabel

Selective and specific inhibit ...... tery disease or heart failure.

@en

P1476

Selective and specific inhibit ...... tery disease or heart failure.

@en

P2093

Prakash Deedwania

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.

Ivabradine for the treatment of stable angina pectoris in octogenarians.

Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells.

P2888

s40265-013-0117-0

P304

1569-1586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40265-013-0117-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257071947

http://www.w3.org/2001/XMLSchema#string

P6179

1013390060

http://www.w3.org/2001/XMLSchema#string

P698

24065301

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

coronary artery disease

P932

3786091

http://www.w3.org/2001/XMLSchema#string